The short answer
Head and neck cancer is a group of diseases, so the subsite comes first. For the oropharynx, p16 status and the PD-L1 combined positive score shape what is offered once disease has spread.
Ask which subsite the tumor started in, because mouth, oropharynx, larynx and nasopharynx behave differently.
For oropharyngeal tumors, HPV status is reported using a p16 stain as part of the routine workup.
In the trial NCI describes, 882 people received pembrolizumab alone, pembrolizumab with chemotherapy, or cetuximab with chemotherapy; 85 percent had a combined positive score of 1 or higher and 43 percent of 20 or higher.
A PD-L1 score was not required to enter that trial, so a low score does not automatically rule immunotherapy out.
Choose how you want to understand this
The full explanation.
Where the tumor started still matters
Head and neck cancer is a group, not one disease. The mouth, the throat behind the mouth, the voice box and the area behind the nose all behave differently.
The NCI summary cited here covers the oropharynx, meaning the tonsils, the base of the tongue, the soft palate and the throat walls, and the trial data below comes from squamous cell disease. Cancers of the mouth, voice box, nasopharynx, sinuses and salivary glands are covered by separate summaries and treated differently. Ask which subsite and which histology yours is, because that answer follows you into every later decision on this page.
HPV, p16 and what they change
For tumors of the oropharynx, NCI reports whether the tumor is linked to HPV using a stain called p16. This is a routine part of the workup for that subsite.
Ask for your result. Ask what it means for you now that the cancer has spread, and be ready for a careful answer rather than a simple one.
The PD-L1 score and what it opens
NCI describes a large trial of 882 people with advanced head and neck cancer. They received pembrolizumab alone, pembrolizumab with chemotherapy, or cetuximab with chemotherapy.
Tumors were scored for PD-L1 using a combined positive score. In that trial, 85 percent scored 1 or higher and 43 percent scored 20 or higher. A score was not required to enter.
Ask what your score is. Ask whether it points to immunotherapy alone or to immunotherapy given with chemotherapy.
If cisplatin is not safe for you
Cisplatin is hard on kidneys and hearing. NCI's summary also covers cetuximab and carboplatin in this disease.
Ask what your kidney function is today. Ask what would be used instead if cisplatin is ruled out.
Treating inside an area already radiated
Radiation given twice to the same tissue carries real risk. NCI reports jawbone breakdown after radiation in this region.
Ask exactly where your first course went and how much it delivered. Ask what a second course would risk near the jaw and the large neck arteries.
Airway, swallowing and bleeding
These are the emergencies to plan for before they happen. Ask what the plan is if breathing becomes difficult, and who to call.
Ask for a speech and swallowing therapist and a dietitian to see you early, before problems set in rather than after. Whether a feeding tube is needed, and when, is a decision they and your team make with you, weighing how you are swallowing now, what treatment is planned, your weight and your own wishes. It is not a yes-or-no to settle from a page. What you can do is get the assessment booked early and ask what would change the answer.
Questions for the oncology visit
- Which subsite did my cancer start in?
- Is my tumor p16 positive?
- What is my PD-L1 combined positive score?
- Does that mean pembrolizumab alone, or with chemotherapy?
- Can I have cisplatin, and what is the alternative?
- Where did my radiation go, and can that area be treated again?
- What is the emergency plan for my airway?
When to get help sooner
- Call 911 or go to an emergency department if your breathing is noisy or you cannot get enough air, or if you cannot swallow your own saliva. Go too for bleeding from the mouth, the neck, or a wound, especially a sudden gush of bright red blood. Large arteries run close to tissue that has been treated, and that bleeding will not stop on its own. Go as well when the thermometer shows 100.4°F (38°C) or higher, or chills take hold, while cisplatin, carboplatin or any other chemotherapy is part of your treatment. Mouth sores, a feeding tube site and treated skin on the neck all give infection a way in, and CDC is clear that a fever during chemotherapy needs seeing at once rather than a message left for the clinic.
- Call your care team the same day if you cough or choke on drinks, if a feeding tube blocks or comes out, if mouth pain or sores stop you taking fluids, or if the neck becomes newly swollen, red or hot. On pembrolizumab, call the same day for a new cough or breathlessness, or for diarrhea several times more often than usual.
- Call your care team within a day or two if swallowing is steadily getting harder, if your voice is weakening or getting hoarser, if weight is dropping, or if skin in a treated area is breaking down. On cisplatin, do the same for new ringing in the ears or a change in hearing.
Related pages
Cancer Staging and Biomarker Testing explain the terms behind a metastatic head and neck cancer diagnosis. Clinical Trial vs Standard Treatment, Palliative Care, and Questions to Ask Your Doctor cover the choices that come next with metastatic head and neck cancer.
Where this comes from
These questions were drawn from current patient guidance for head and neck cancer:
Words to know
Tap any term to see what it means.
Common questions
Why does the subsite matter so much?
Head and neck cancer is a group rather than one disease. The NCI summary cited here covers the oropharynx: the tonsils, base of tongue, soft palate and throat walls. Cancers of the mouth, voice box, nasopharynx, sinuses and salivary glands have their own summaries and their own treatment, so read this as oropharyngeal squamous cell material unless your team says otherwise.
What does the PD-L1 combined positive score change?
It is one of several things weighed when choosing between pembrolizumab alone and pembrolizumab given with chemotherapy, alongside how fast the disease is moving, your symptoms and how well you are. It applies to squamous cell head and neck cancer, which is the histology the trial enrolled. In the trial NCI describes, 85 percent of tumors scored 1 or higher and 43 percent scored 20 or higher, and a score was not required to take part.
What if cisplatin is not safe for me?
Cisplatin is hard on the kidneys and hearing. NCI's summary also covers cetuximab and carboplatin, so ask what your kidney function is today and what would be used instead.
Questions to ask your doctor
Being prepared helps you get the most out of your appointments. Save or print these questions.
Tap a question to save it to your list (kept on this device).
Your next step
Turn this topic into questions for your next appointment.
Speak With Trained Specialists & Human Navigators
Cancer Explained provides educational guidance, but does not replace trained specialists, social workers, or your medical team.
Talk to a trained cancer information specialist
Free, confidential assistance from NCI Cancer Information Service via phone, chat, or email.
Contact your oncology team
Locate after-hours contact numbers, portal messages, or urgent triage phone lines.
Find a patient navigator
Get one-on-one help with appointments, logistics, translation, and care coordination.
Find a genetic counselor
Discuss inherited mutation risk, family history, and genetic testing options.
Find an oncology social worker
Access emotional counseling, family support groups, and mental health resources.
Find a financial navigator
Locate copay assistance foundations, grant programs, and lodging/travel support.
Find a clinical-trial specialist
Search matching studies and speak with NCI trial information specialists.
Get urgent help
Immediate emergency guidance for fever (>100.4°F during chemo), severe pain, or shortness of breath.
Help Us Improve This Guide
Did this explanation answer your question and help you determine your next step?
Know someone who needs this?
Plenty of people are looking for something like this and do not know where to start. If this would help a friend or someone you love, send it on — we have written an opening line so you do not have to stare at an empty message. You can change every word of it.
Your message is written and sent in your own email or messaging app — we never see who you send it to, and nothing is added to any list.
Plain-language explanation of the published sources cited on this page. AI-assisted, source-checked, not clinician-reviewed.
Sources last checked: 2026-08-13 what this meansLast updated: 2026-08-19Next planned review: 2027-07-30
How this page was created
Cancer Explained does not originate medical claims. Every page restates guidance already published by the National Cancer Institute, the CDC, the USPSTF and the FDA, in plain language, with the source cited so you can check the original yourself. AI does the translating and organizing; automated checks test claims, citations, clarity and safety before anything publishes. We do not employ clinicians and do not intend to — our work is translation and navigation, not clinical judgment. Nothing here is personal medical advice, and no page can account for your particular situation.
Editorial status — Source checked. This page was written with AI assistance and checked line by line against the sources listed on it. That confirms the sources support what the page says. It is not a medical review, and it does not confirm the page is complete or right for your situation.
High-risk topic — talk to your care team. This topic can involve urgent, individual medical decisions. This page is general education only: it cannot tell you whether your situation is an emergency or what you personally should do. Follow your oncology team's instructions and contact them for individual guidance.
Human medical review: not completed. Pages here are not signed off by a clinician before they publish. That is not an oversight we are quietly working around: we restate published guidance and cite it, so the authority belongs to the source rather than to us, and every page names where its claims come from — you can verify us instead of trusting us. Where a volunteer clinician has reviewed a page, their name and credentials appear on it; where no name appears, no clinician has checked it. We are glad to have reviewers and are recruiting them, and we do not hold pages back waiting for one. Use this site to understand your situation and to ask better questions of the people treating you.
How this page was created
Cancer Explained does not originate medical claims. Every page restates guidance already published by the National Cancer Institute, the CDC, the USPSTF and the FDA, in plain language, with the source cited so you can check the original yourself. AI does the translating and organizing; automated checks test claims, citations, clarity and safety before anything publishes. We do not employ clinicians and do not intend to — our work is translation and navigation, not clinical judgment. Nothing here is personal medical advice, and no page can account for your particular situation.
Editorial status: Source checked — This page was written with AI assistance and checked line by line against the sources listed on it. That confirms the sources support what the page says. It is not a medical review, and it does not confirm the page is complete or right for your situation.
Human medical review: not completed. Pages here are not signed off by a clinician before they publish. That is not an oversight we are quietly working around: we restate published guidance and cite it, so the authority belongs to the source rather than to us, and every page names where its claims come from — you can verify us instead of trusting us. Where a volunteer clinician has reviewed a page, their name and credentials appear on it; where no name appears, no clinician has checked it. We are glad to have reviewers and are recruiting them, and we do not hold pages back waiting for one. Use this site to understand your situation and to ask better questions of the people treating you.
Read more about our editorial process, our use of AI, and our corrections policy.
Spotted a problem? Report an error — a factual mistake, broken or outdated source, confusing wording, or anything that seems unsafe. Please do not include names, medical record numbers, dates of birth, addresses, or other identifying medical information in your report.
After using this page, do you understand what to do next?
Anonymous — we only record the answer, never who gave it.
Related articles
- What Is Head and Neck Cancer?
- Cancer Staging: What the Stage Means
- Biomarker Testing and Precision Medicine
- Getting a Second Opinion After a Diagnosis
- Questions to Ask About Head and Neck Cancer Treatment
- Head and Neck Cancer Recurrence: What to Ask
- Head and Neck Cancer Survivorship Follow-Up Questions
- Metastatic Cancer: When Cancer Spreads
Still have questions?
Educational answers, plain language
Free to print and share